세계의 말초 인터벤션 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Peripheral Interventions Market size is anticipated to grow from USD 10.99 Billion in 2024 to USD 25.22 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.67% during the forecast period of 2026 to 2033.

The global peripheral interventions market is poised for significant growth, driven by the increasing prevalence of peripheral vascular diseases and the rising demand for minimally invasive treatment options. Peripheral interventions encompass a range of procedures aimed at treating conditions affecting the peripheral arteries and veins, including angioplasty, stenting, and thrombectomy. As healthcare providers seek to improve patient outcomes and reduce recovery times, the adoption of peripheral intervention techniques is expected to rise significantly, fostering innovation and investment in this critical market.

Moreover, advancements in interventional devices and technologies are set to transform the peripheral interventions landscape. The development of advanced catheter systems, drug-eluting stents, and bioresorbable scaffolds is enhancing the effectiveness and safety of peripheral interventions. Additionally, the integration of imaging technologies, such as intravascular ultrasound and optical coherence tomography, is improving procedural accuracy and outcomes. As the focus on patient-centered care continues to grow, the demand for innovative peripheral intervention solutions that offer enhanced performance and reduced complications will continue to rise.

In addition, the increasing emphasis on preventive healthcare and early intervention is expected to shape the future of the peripheral interventions market. As patients and healthcare providers recognize the importance of managing peripheral vascular diseases proactively, the role of interventional procedures in routine care is becoming increasingly vital. Collaborative efforts between medical device manufacturers, vascular specialists, and healthcare institutions will be essential in driving these innovations, ensuring that the peripheral interventions market remains responsive to the evolving needs of patients and healthcare systems.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Catheters
• Sheath
• Stents
• Bare metal Stents
• Drug-eluting Stents
• Guide wires
• Atherectomy devices
• Embolic devices
• Thrombectomy devices
• IVC filters
• Others

By Application

• Peripheral artery disease
• Venous thromboembolism
• Others

By End-use

• Hospitals
• Catheterization laboratories
• Ambulatory surgical centers
• Others
• COMPANIES PROFILED
• Biotronik SE & Co. KG
• Teleflex Incorporated
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• W. L. Gore & Associates Inc.
• Cardinal Health Inc.
• AngioDynamics Inc.
• Medtronic
• B. Braun Melsungen AG
• Terumo Corporation
• Becton Dickinson and Company (C.R. Bard)
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PERIPHERAL INTERVENTIONS INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PERIPHERAL INTERVENTIONS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product
• 5.4. Catheters Historic and Forecast Sales By Regions
• 5.5. Sheath Historic and Forecast Sales By Regions
• 5.6. Stents (Bare metal Stents, Drug-eluting Stents, Other) Historic and Forecast Sales By Regions
• 5.7. Guide Wires Historic and Forecast Sales By Regions
• 5.8. Atherectomy Devices Historic and Forecast Sales By Regions
• 5.9. Embolic Devices Historic and Forecast Sales By Regions
• 5.10. Thrombectomy Devices Historic and Forecast Sales By Regions
• 5.11. IVC filters Historic and Forecast Sales By Regions
• 5.12. Others Historic and Forecast Sales By Regions

6. GLOBAL PERIPHERAL INTERVENTIONS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Application
• 6.4. Peripheral Artery Disease Historic and Forecast Sales By Regions
• 6.5. Venous Thromboembolism Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL PERIPHERAL INTERVENTIONS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data
• 7.3. Analysis By End-use
• 7.4. Hospitals Historic and Forecast Sales By Regions
• 7.5. Catheterization Laboratories Historic and Forecast Sales By Regions
• 7.6. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PERIPHERAL INTERVENTIONS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East Africa By Segment Sales Analysis
  • 8.7.3 Middle East Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PERIPHERAL INTERVENTIONS COMPANIES

• 9.1. Peripheral Interventions Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF PERIPHERAL INTERVENTIONS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Biotronik SE Co. KG
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Teleflex Incorporated
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Abbott Laboratories
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Boston Scientific Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Cook Medical
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. W.L. Gore Associates Inc
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Cardinal Health Inc
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. AngioDynamics Inc
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Medtronic
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. B.Braun Melsungen AG
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. TerumCorporation
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Becton Dickinson And Company (C.R. Bard)
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies